VeriMomhypericum perforatum leaf extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
Pregnancy-safe products containing hypericum perforatum leaf extract
Related ingredients
Frequently asked questions
- hypericum perforatum leaf extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
- hypericum perforatum leaf extract emzirirken güvenli mi?
- No regulatory harmonised reproductive/breastfeeding classification. While oral St. John's wort is known for systemic drug interactions and there are reports of transfer with systemic use, topical cosmetic use of the leaf extract is not established to cause significant transfer into breastmilk; therefore hazard and mechanism are scored 0 and exposure is low but measurable (e=1). Sources: PubMed (systemic use literature), CosIng, ECHA (no harmonised CLP).
- hypericum perforatum leaf extract bebek cildi için güvenli mi?
- No evidence of a reproductive or developmental hazard specific to infants from topical exposure to Hypericum perforatum leaf extract; mechanism of reproductive toxicity is not demonstrated. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight, dermal exposure is increased relative to adults, so exposure is increased to moderate (adult e=1 → infant e=2). Note: phototoxic constituents (e.g., hypericin) may increase skin reaction risk but that is separate from reproductive classification. Sources: CosIng, PubMed (phototoxicity literature), ECHA (no harmonised CLP).
- VeriMom hypericum perforatum leaf extract nasıl puanlıyor?
- VeriMom hypericum perforatum leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hypericum perforatum leaf extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.